And yes, mergerman, consolidations can take years, especially when standard valuation metrics reach outrageous, nose bleed levels just as the financial markets enter a prolonged period of multiple contraction. Here are more financial facts that clearly show Celgene price performance during the Barer years was well within parameters that most self-respecting advisors would consider admirable.

Dec 2004
Trailing P/E 82.9
Price/Sales 11.5
Price/Book 9.1

Dec 2005
Trailing P/E 170.5
Price/Sales 20.2
Price/Book 17.1

Dec 2006
Trailing P/E 287.7
Price/Sales 22.5
Price/Book 10.3

Dec 2007
Trailing P/E 78.3
Price/Sales 12.6
Price/Book 6.2

Dec 2008
Trailing P/E 33.5
Price/Sales 10.9
Price/Book 7.0

Dec 2009
Trailing P/E 32.9
Price/Sales 9.5
Price/Book 5.8

Dec 2010
Trailing P/E 31.1
Price/Sales 7.5
Price/Book 4.6

Dec 2011
Trailing P/E 23.4
Price/Sales 6.4
Price/Book 5.6